Exclusive license for medical marijuana treamtent?
December 21, 2011 2:11 PM Subscribe
The US National Insitutes of Health recently filed notice of a prospective grant to give an exclusive license to New York based Kannalife for Development of Cannabinoid(s) and Cannabidiol(s) (i.e. marijuana) Based Therapeutics To Treat Hepatic Encephalopathy in Humans. Toke of The Town covers the issue, including an interview with Kannalife CEO Dean Pethanas.
This thread has been archived and is closed to new comments